Transscleral sustained ranibizumab delivery using an episcleral implantable device: Suppression of laser-induced choroidal neovascularization in rats.

Nagai, Nobuhiro

Transscleral sustained ranibizumab delivery using an episcleral implantable device: Suppression of laser-induced choroidal neovascularization in rats. [electronic resource] - International journal of pharmaceutics Aug 2019 - 118458 p. digital

Publication Type: Journal Article

1873-3476

10.1016/j.ijpharm.2019.118458 doi


Angiogenesis Inhibitors--administration & dosage
Animals
Chitosan--administration & dosage
Choroidal Neovascularization--drug therapy
Collagen--administration & dosage
Drug Implants--administration & dosage
Drug Liberation
Eye--drug effects
Fluorescein-5-isothiocyanate--administration & dosage
Gelatin--administration & dosage
Lasers
Male
Methacrylates--administration & dosage
Polyethylene Glycols--administration & dosage
Ranibizumab--administration & dosage
Rats, Sprague-Dawley
Serum Albumin--administration & dosage